SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000812295-18-000021
Filing Date
2018-02-06
Accepted
2018-02-06 16:12:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUS CAPITAL MANAGEMENT 12/31/17 <5% ANNUAL CLOSEOUT tril2102018.txt SC 13G/A 5602
  Complete submission text file 0000812295-18-000021.txt   7404
Mailing Address 151 DETROIT ST. DENVER CO 80206-4805
Business Address 151 DETROIT ST. DENVER CO 80206-4805 3033333863
JANUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000812295 (see all company filings)

IRS No.: 753019302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 18577745
SIC: 2834 Pharmaceutical Preparations